| RCKT Stock | | | USD 14.39 0.19 1.34% |
Rocket Pharmaceuticals financial indicator trend analysis is much more than just breaking down Rocket Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rocket Pharmaceuticals is a good investment. Please check the relationship between Rocket Pharmaceuticals Other Stockholder Equity and its Accounts Payable accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.
Other Stockholder Equity vs Accounts Payable
Other Stockholder Equity vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Rocket Pharmaceuticals Other Stockholder Equity account and
Accounts Payable. At this time, the significance of the direction appears to have weak relationship.
The correlation between Rocket Pharmaceuticals' Other Stockholder Equity and Accounts Payable is 0.33. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Rocket Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Rocket Pharmaceuticals' Other Stockholder Equity and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Rocket Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Other Stockholder Equity i.e., Rocket Pharmaceuticals' Other Stockholder Equity and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.33 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Other Stockholder Equity
Accounts Payable
An accounting item on the balance sheet that represents Rocket Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Rocket Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Rocket Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rocket Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
For more information on how to buy Rocket Stock please use our
How to Invest in Rocket Pharmaceuticals guide.At this time, Rocket Pharmaceuticals'
Selling General Administrative is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 2.6
B in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 203.6
M in 2024.
Rocket Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Rocket Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rocket Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to
measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.